# Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery

> **NCT01390896** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 329 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

- **DRUG:** Fondaparinux Sodium

## Key facts

- **NCT ID:** NCT01390896
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390896, "Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01390896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*